Multiple myeloma: challenges with deciding the optimal sequencing strategy
Main Authors: | Anushka Walia, Alyson Haslam, Jordan Tuia, Vinay Prasad |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1231720/full |
Similar Items
-
A Retrospective Study of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
by: Wang Y, et al.
Published: (2020-09-01) -
Comparison of bortezomib-cyclophosphamide-dexamethasone <em>versus</em> bortezomib-dexamethasone based regimens in newly diagnosed multiple myeloma patients
by: Rafiye Ciftciler, et al.
Published: (2020-05-01) -
VAD Regimen as Initial Treatment for Multiple Myeloma
by: Mohammad Ali Mashhadi, et al.
Published: (2010-12-01) -
VAD Regimen as Initial Treatment for Multiple Myeloma
by: Mohammad Ali Mashhadi, et al.
Published: (2010-10-01) -
Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
by: Shiyuan Zhou, et al.
Published: (2023-09-01)